Contact this trialFirst, we need to learn more about you.
PI3K-gamma Inhibitor
IPI-549 +1 More for Adrenocortical Cancer
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial will study the effects of a new drug, IPI-549, on patients with advanced solid tumors. The investigators will evaluate how well the drug is tolerated and how it affects the body.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.